{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "regularMarketChangePercent": 0.0, "regularMarketPrice": 37.0, "earningsTimestamp": 1683878400, "earningsTimestampStart": 1691049600, "earningsTimestampEnd": 1691395200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -6.94, "epsForward": -20.4, "sharesOutstanding": 192644000, "bookValue": 5.456, "fiftyDayAverage": 45.8, "fiftyDayAverageChange": -8.799999, "fiftyDayAverageChangePercent": -0.19213973, "twoHundredDayAverage": 56.275, "twoHundredDayAverageChange": -19.275002, "twoHundredDayAverageChangePercent": -0.34251446, "marketCap": 7127827968, "forwardPE": -1.8137255, "priceToBook": 6.781525, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1127952000000, "priceHint": 2, "marketState": "CLOSED", "exchange": "JPX", "shortName": "ONCOTHERAPY SCIENCE INC", "longName": "OncoTherapy Science, Inc.", "messageBoardId": "finmb_9221339", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "market": "jp_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketTime": 1683872100, "regularMarketDayHigh": 38.0, "regularMarketDayRange": "37.0 - 38.0", "regularMarketDayLow": 37.0, "regularMarketVolume": 1195000, "regularMarketPreviousClose": 37.0, "bid": 37.0, "ask": 38.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 37.0, "averageDailyVolume3Month": 1520079, "averageDailyVolume10Day": 3127330, "fiftyTwoWeekLowChange": 3.0, "fiftyTwoWeekLowChangePercent": 0.0882353, "fiftyTwoWeekRange": "34.0 - 70.0", "fiftyTwoWeekHighChange": -33.0, "fiftyTwoWeekHighChangePercent": -0.47142857, "fiftyTwoWeekLow": 34.0, "fiftyTwoWeekHigh": 70.0, "symbol": "4564.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1-2 Higashida-cho", "address2": "Kawasaki-ku", "city": "Kawasaki", "zip": "213-0012", "country": "Japan", "phone": "81 4 4201 6429", "fax": "81 4 4201 6473", "website": "https://www.oncotherapy.co.jp", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "OncoTherapy Science, Inc. engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer. The company's clinical development product pipeline also comprise cancer- specific peptide vaccines, including S-588410, which is in Phase III clinical trials for the treatment esophageal cancer, as well as in Phase II clinical trials for the treatment of bladder cancer; S-488210 that is in Phase I/II clinical trials for the treatment of head and neck cancer; and S-588210, which is in Phase I clinical trials for the treatment of solid tumor. In addition, it is developing antibody drugs consisting of OTSA101, which is in Phase I clinical trials for synovial sarcoma; and KHK6640, an anti-amyloid beta peptide antibody that is Phase I clinical trials for Alzheimer's disease. The company was incorporated in 2001 and is headquartered in Kawasaki, Japan.", "fullTimeEmployees": 67, "companyOfficers": [{"maxAge": 1, "name": "Hatsuo  Kato", "age": 79, "title": "Exec. Chairman", "yearBorn": 1943, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Junichi  Shimada", "title": "Pres, CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Jae-Hyun  Park", "age": 46, "title": "Chief Scientific Officer & Director", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}